Amyloid extraction from neurodegenerative disease tissues for structural studies

Area of Science:

• Neuroscience
• Biochemistry
• Structural Biology

Background:

• Amyloid aggregates are key in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD).
• Structural analysis of these filaments requires specialized extraction methods to preserve integrity and remove interfering tissue components.

Purpose of the Study:

• To present three complementary methods for isolating amyloid-beta (Aβ) filaments from human brain tissue.
• To enable high-resolution structural studies of Aβ filaments using cryo-electron microscopy (cryo-EM).
• To provide guidance for selecting and implementing optimal protocols based on tissue type and downstream analysis.

Main Methods:

• Three distinct protocols for isolating Aβ filaments from human brain tissue were developed and validated.
• The methods are designed to minimize structural perturbation during extraction.
• Protocols were adapted for the extraction of tau, α-synuclein, and TDP-43 filaments.

Main Results:

• High-resolution cryo-EM structural studies of Aβ filaments were achieved, reaching resolutions of 2.0-3.5 Å.
• Distinct conformational polymorphs of amyloid filaments in AD and other neurodegenerative diseases were identified.
• The extraction protocols demonstrated broad applicability across different protein aggregates.

Conclusions:

• The presented methods facilitate detailed structural investigations of disease-associated filaments.
• Understanding filament structures is crucial for developing targeted therapeutics for neurodegenerative diseases.
• These techniques support structure-based drug design for conditions like AD, PD, ALS, and FTD.